Clinical Trials Sponsored by Lixte

Total 7 results

Lixte Biotechnology Holdings, Inc.

Completed

Phase I Study of LB-100 With Docetaxel in Solid Tumors

Neoplasms | Cancer | Tumors

United States
Lixte Biotechnology Holdings, Inc.

Unknown

A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

United States
M.D. Anderson Cancer Center
GSK Pharma; Lixte

Recruiting

Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100

Ovarian Clear Cell Carcinoma

United States
Lite-On Technology Corporation H.S.P.B

Unknown

Performance Evaluation of In-Vitro Diagnostic Device

Blood Routine Examination

Taiwan
Gillette Children's Specialty Healthcare
Lite Run Inc.

Completed

Post-operative Lite Run Study

Cerebral Palsy | Neurologic Disorder | Spina Bifida | Chromosome Abnormality

United States
Lite Run Inc.
Minneapolis Veterans Affairs Medical Center; TREAT

Unknown

Evaluation of a Novel Gait Training Device to Support Body Weight

Stroke | Brain Injuries, Traumatic | Spinal Cord Injuries | Gait Disorders, Neurologic
Fundació Eurecat
Centre de Recerca en Economia i Desenvolupament Agroalimentari-UPC-IRTA (CREDA) and other collaborators

Enrolling by invitation

Switching Mediterranean Consumers to Mediterranean Sustainable Healthy Dietary Patterns

Healthy Subjects | Family | Behavior, Health

Spain

3

Subscribe